Free Trial

Kentucky Retirement Systems Insurance Trust Fund Has $935,000 Stock Holdings in DaVita Inc. (NYSE:DVA)

DaVita logo with Medical background

Kentucky Retirement Systems Insurance Trust Fund raised its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 357.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,252 shares of the company's stock after purchasing an additional 4,886 shares during the period. Kentucky Retirement Systems Insurance Trust Fund's holdings in DaVita were worth $935,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC acquired a new stake in shares of DaVita in the third quarter worth $25,000. Blue Trust Inc. grew its stake in shares of DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company's stock worth $54,000 after acquiring an additional 119 shares during the last quarter. Quarry LP acquired a new stake in shares of DaVita in the third quarter worth $60,000. Venturi Wealth Management LLC grew its stake in shares of DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after acquiring an additional 152 shares during the last quarter. Finally, Versant Capital Management Inc grew its stake in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after acquiring an additional 169 shares during the last quarter. Institutional investors and hedge funds own 90.12% of the company's stock.

Analysts Set New Price Targets

Separately, Barclays raised their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $162.80.

Get Our Latest Research Report on DaVita

DaVita Stock Performance

DVA stock traded down $3.59 during midday trading on Friday, hitting $142.33. The stock had a trading volume of 1,605,084 shares, compared to its average volume of 845,867. The firm has a market capitalization of $11.39 billion, a price-to-earnings ratio of 13.25, a P/E/G ratio of 1.14 and a beta of 0.94. DaVita Inc. has a 52 week low of $120.78 and a 52 week high of $179.60. The stock has a 50-day simple moving average of $161.24 and a 200 day simple moving average of $157.81. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities research analysts anticipate that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

See Also

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines